TickerGuard
Buy Day today: Poor (42) Weak market breadth · no major macro event
CGC

Canopy Growth Corp

Healthcare · Drug Manufacturers - Specialty & Generic

0.427$ -10.0% vs. previous close Closing price · As of: Nov 20, 2026

Investor relations

Report Dates

Investor relations overview for Canopy Growth Corp (CGC): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/06/2026.

Next report 11/06/2026
Last report 11/06/2026
Earnings surprise by quarter (%)
Q4 23 · -366.0 % 23 Q1 24 · -128.9 % 24 Q2 24 · -305.4 % 24 Q3 24 · -284.4 % 24 Q4 24 · -360.9 % 24 Q1 25 · -472.0 % 25 Q2 25 · -58.3 % 25 Q3 25 · 90.9 % 25 Q4 25 · -180.0 % 25 Q1 26 · -183.3 % 26 Q2 26 · 50.0 % 26 Q3 26 · -250.0 % 26

EPS estimate beaten

Full history 11 of 48 quarters (23%)
Last 16 quarters 3 of 16 quarters (19%)

Earnings Call Transcripts

Search all transcripts →

  • 11/06/2026 Earnings Call Q3 2026 Open →
  • 08/07/2026 Earnings Call Q2 2026 Open →
  • 02/06/2026 Earnings Call Q4 2025 Open →
  • 11/07/2025 Earnings Call Q3 2025 Open →
  • 08/08/2025 Earnings Call Q2 2025 Open →

News on This Stock

  • 11/06/2026 Canopy Growth Corp (CGC): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗
  • 10/23/2026 Canopy Growth Corp (CGC): Submission of Matters to a Vote of Security Holders · sec.gov Open ↗
  • 10/16/2026 Canopy Growth Corp (CGC): Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: November 20, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?